27 results match your criteria: "State University of New York-Downstate School of Public Health[Affiliation]"
J Am Coll Cardiol
September 2024
Department of Cardiovascular Medicine, Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
Eur J Heart Fail
April 2024
Université Paris-Cité, INSERMU1148 and AP-HP Hopital Bichat, Paris, France.
J Am Coll Cardiol
November 2023
Université Paris-Cité, INSERMU1148 and AP-HP Hopital Bichat, Paris, France; French Alliance for Cardiovascular Trials, Paris, France.
Am J Prev Cardiol
September 2022
Imperial Centre for Cardiovascular Disease Prevention, Imperial College, London, UK.
Background: Nonalcoholic fatty liver disease (NAFLD) is common among patients with type 2 diabetes mellitus (T2DM) and is associated with increased risk for coronary atherosclerosis and acute cardiovascular (CV) events. We employed the validated, non-invasive Angulo NAFLD fibrosis score (FS) in an intervention study in patients with T2DM and recent acute coronary syndrome (ACS) to determine the association of FS with CV risk and treatment response to apabetalone. Apabetalone is a novel selective inhibitor of the second bromodomain of bromodomain and extra-terminal (BET) proteins, epigenetic regulators of gene expression.
View Article and Find Full Text PDFBMJ Open
June 2021
Department of Environmental and Occupational Health Sciences, State University of New York Downstate School of Public Health, Brooklyn, New York, USA.
Objectives: This study sought to assess the association between long working hours, psychosocial safety climate (PSC), work engagement (WE) and new major depression symptoms emerging over the next 12 months. PSC is the work climate supporting workplace psychological health.
Setting: Australian prospective cohort population data from the states of New South Wales, Western Australia and South Australia.
Ann Intern Med
August 2021
University of Michigan, Ann Arbor, Michigan (B.P.).
New Solut
November 2021
Department of Community Health Sciences, State University of New York-Downstate School of Public Health, NY, USA.
The National Institute of Environmental Health Sciences Worker Training Program piloted an Opioids and the Workplace: Prevention and Response training tool and program in 2019. The pilot trainees ( = 97) were surveyed (= 27) and interviewed ( = 6) six months posttraining, and those who downloaded the training tool from the Worker Training Program website (= 87) were surveyed ( = 19) and interviewed ( = 1) two to six months postdownload, to evaluate the impact of the training program. Workplace policy and program-level actions were reported less frequently than individual-level actions by trainees, except for planning and conducting training and education.
View Article and Find Full Text PDFN Engl J Med
January 2021
From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B., C.P.C.); Colorado Prevention Center Clinical Research and Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora (M.S.); State University of New York Downstate School of Public Health, Brooklyn (M.S.); Université de Paris, French Alliance for Cardiovascular Trials, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, INSERM Unité 1148 (P.G.S.), and Paris Sorbonne University and Groupe Hospitalier Paris Saint Joseph (M.K.), Paris; Li Ka Shing Knowledge Institute (L.A.L., S.V.) and the Divisions of Endocrinology and Metabolism (L.A.L.) and Cardiac Surgery (S.V.), St. Michael's Hospital, and the Departments of Medicine and Nutritional Sciences (L.A.L) and Surgery and Pharmacology and Toxicology (S.V.), University of Toronto, Toronto; University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.), and Lexicon Pharmaceuticals, The Woodlands (P.L.) - both in Texas; Vanderbilt University, Nashville (J.B.L.); the Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland (M.C.R.); University of Groningen-University Medical Center Groningen, Groningen, the Netherlands (A.A.V); Azienda Socio Sanitaria Territoriale Spedali Civili and University of Brescia, Brescia, Italy (M.M.); Karolinska Institutet, Stockholm (L.H.L.); Yale University, New Haven, CT (J.M.T.); Georgetown University, Washington, DC (C.S.W.); Wroclaw Medical University, Wroclaw, Poland (P.P.); Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L.); and the University of Michigan, Ann Arbor (B.P.).
N Engl J Med
January 2021
From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B., C.P.C., B.M.S.); Colorado Prevention Center Clinical Research and Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora (M.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.); the University of Michigan, Ann Arbor (B.P.); Li Ka Shing Knowledge Institute and the Division of Endocrinology and Metabolism, St. Michael's Hospital, and the Departments of Medicine and Nutritional Sciences, University of Toronto (L.A.L.), and the Division of Nephrology (D.Z.I.C.) and the Cardiovascular Division, Department of Medicine, Women's College Hospital and Peter Munk Cardiac Centre (J.A.U.), University Health Network, University of Toronto - all in Toronto; the University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.), and Lexicon Pharmaceuticals, The Woodlands (P.L.) - both in Texas; Vanderbilt University Medical Center, Nashville (J.B.L., J.P.D.); the Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland (M.C.R.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City (M.N.K.); the School of Life and Health Sciences, Aston University, Birmingham (C.J.B.), and the Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London (K.K.R.) - both in the United Kingdom; the Department of Medicine, Estudios Clínicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L.); and Université de Paris, French Alliance for Cardiovascular Trials, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, INSERM Unité 1148, Paris (P.G.S.).
Circulation
November 2020
Université de Paris, Hôpital Bichat, and Institut National de la Santé et de la Recherche Médicale, Unit 1148, France (P.G.S.).
N Engl J Med
November 2018
From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).
Background: Patients who have had an acute coronary syndrome are at high risk for recurrent ischemic cardiovascular events. We sought to determine whether alirocumab, a human monoclonal antibody to proprotein convertase subtilisin-kexin type 9 (PCSK9), would improve cardiovascular outcomes after an acute coronary syndrome in patients receiving high-intensity statin therapy.
Methods: We conducted a multicenter, randomized, double-blind, placebo-controlled trial involving 18,924 patients who had an acute coronary syndrome 1 to 12 months earlier, had a low-density lipoprotein (LDL) cholesterol level of at least 70 mg per deciliter (1.
Environ Int
October 2018
Life Science Centre, University of Düsseldorf, Merowingerplatz 1a, Düsseldorf 40225, Germany. Electronic address:
Background: The World Health Organization (WHO) and the International Labour Organization (ILO) are developing a joint methodology for estimating the national and global work-related burden of disease and injury (WHO/ILO joint methodology), with contributions from a large network of experts. In this paper, we present the protocol for two systematic reviews of parameters for estimating the number of deaths and disability-adjusted life years of ischaemic heart disease from exposure to long working hours, to inform the development of the WHO/ILO joint methodology.
Objectives: We aim to systematically review studies on occupational exposure to long working hours (Systematic Review 1) and systematically review and meta-analyse estimates of the effect of long working hours on ischaemic heart disease (Systematic Review 2), applying the Navigation Guide systematic review methodology as an organizing framework.
Epidemiology
November 2018
Center for Occupational and Environmental Health, School of Medicine and Program in Public Health, University of California, Irvine, CA Center for Transdisciplinary Research in Psychology, School of Psychology, Universidad Autónoma del Estado de Morelos, Cuernavaca, México,
Am J Public Health
March 2018
Paul A. Landsbergis is with the State University of New York-Downstate School of Public Health, Brooklyn, NY. BongKyoo Choi and Marnie Dobson are with the Center for Occupational and Environmental Health, University of California, Irvine. Grace Sembajwe is with the City University of New York Graduate School of Public Health and Health Policy, New York, NY. Craig Slatin is with the Department of Public Health, University of Massachusetts, Lowell. Linda Delp is with the Labor Occupational Safety and Health Program, University of California, Los Angeles. C. Eduardo Siqueira is with the College of Public and Community Service, University of Massachusetts, Boston. Peter Schnall is with the Center for Social Epidemiology, Marina Del Rey, CA. Sherry Baron is with the Barry Commoner Center for Health and the Environment, Queens College, City University of New York, Queens, NY.
SSM Popul Health
December 2017
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Research on racial/ethnic health disparities and socioeconomic position has not fully considered occupation. However, because occupations are racially patterned, certain occupational characteristics may explain racial/ethnic difference in health. This study examines the role of occupational characteristics in racial/ethnic disparities in all-cause mortality.
View Article and Find Full Text PDFEpidemiology
March 2018
Center for Transdisciplinary Research in Psychology, School of Psychology, Universidad Autónoma del Estado de Morelos, Mexico, Center for Occupational and Environmental Health, School of Medicine and Program in Public Health, University of California, Irvine, CA State University of New York Downstate School of Public Health, Brooklyn, NY.
J Occup Environ Med
April 2017
Division of Environmental and Occupational Health Sciences, State University of New York-Downstate School of Public Health, New YorkDepartment of Human Science, Georgetown University School of Nursing and Health Studies, Washington, DC.
Subst Abuse Rehabil
September 2016
Department of Community Health Sciences, State University of New York Downstate School of Public Health, Brooklyn, NY, USA.
Objective: Peer support can be defined as the process of giving and receiving nonprofessional, nonclinical assistance from individuals with similar conditions or circumstances to achieve long-term recovery from psychiatric, alcohol, and/or other drug-related problems. Recently, there has been a dramatic rise in the adoption of alternative forms of peer support services to assist recovery from substance use disorders; however, often peer support has not been separated out as a formalized intervention component and rigorously empirically tested, making it difficult to determine its effects. This article reports the results of a literature review that was undertaken to assess the effects of peer support groups, one aspect of peer support services, in the treatment of addiction.
View Article and Find Full Text PDFJ Occup Environ Med
November 2015
Department of Environmental and Occupational Health Sciences (Dr Landsbergis, Mr Koutsouras), State University of New York Downstate School of Public Health, Brooklyn; School of Public Health (Dr Diez-Roux), Drexel University, Philadelphia, Pennsylvania; Division of Surveillance, Hazard Evaluations, and Field Studies (Dr Fujishiro), National Institute for Occupational Safety and Health, Cincinnati, Ohio; Barry Commoner Center for Health and the Environment (Dr Baron), Queens College, New York; Department of Environmental and Occupational Health Sciences (Dr Kaufman), University of Washington, Seattle; Department of Preventive Medicine (Dr Meyer), Mount Sinai School of Medicine; Department of Medicine (Dr Shimbo), Columbia University, New York; Department of Biostatistics (Ms Shrager), University of Washington, Seattle; and Department of Epidemiology (Dr Szklo), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Objective: To assess associations of occupational categories and job characteristics with prevalent hypertension.
Methods: We analyzed 2517 Multi-Ethnic Study of Atherosclerosis participants, working 20+ hours per week, in 2002 to 2004.
Results: Higher job decision latitude was associated with a lower prevalence of hypertension, prevalence ratio = 0.
J Occup Environ Med
November 2014
From the Biostatistics and Epidemiology Branch (Drs Charles, Fekedulegn, Burchfiel, and Andrew), Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV; Department of Environmental and Occupational Health Sciences (Dr Landsbergis), State University of New York Downstate Medical Center, NY, and State University of New York Downstate School of Public Health, Brooklyn, NY; Division of Surveillance, Hazard Evaluation, and Field Studies (Drs Baron and Fujishiro), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH; Department of Environmental and Occupational Health Sciences (Dr Kaufman), School of Public Health, University of Washington, Seattle, WA; Department of Biostatistics (Ms Stukovsky), School of Public Health, University of Washington, Seattle, WA; Department of Social Sciences and Health Policy (Dr Foy), Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC; and School of Public Health (Dr Diez Roux), Drexel University, Philadelphia, PA. Research was conducted at the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Objective: To investigate associations of work hours, job control, job demands, job strain, and occupational category with brachial artery flow-mediated dilation (FMD) in 1499 Multi-Ethnic Study of Atherosclerosis participants.
Methods: Flow-mediated dilation was obtained using high-resolution ultrasound. Mean values of FMD were examined across categories of occupation, work hours, and the other exposures using regression analyses.
Occup Environ Med
October 2015
Cardiovascular Medicine Division, University of Wisconsin, Madison, Wisconsin, USA.
Objectives: The role of occupation in the development of cardiovascular disease (CVD) remains a topic of research because few studies have examined longitudinal associations, and because occupation can be an indicator of socioeconomic position (SEP) and a proxy for hazard exposure. This study examines associations of occupational category as an SEP marker and selected occupational exposures with progression of the subclinical carotid artery disease.
Methods: A community-based, multiethnic sample (n=3109, mean age=60.
Am J Public Health
March 2014
BongKyoo Choi, Sangbaek Ko, Marnie Dobson, and Peter Schnall are with the Center for Occupational and Environmental Health, School of Medicine, University of California, Irvine. Sangbaek Ko is also with Yonsei University, Wonju College of Medicine, Wonju, South Korea. Paul Landsbergis is with the State University of New York Downstate School of Public Health, New York.
Am J Epidemiol
September 2013
Department of Environmental and Occupational Health Sciences, State University of New York-Downstate School of Public Health, Brooklyn, NY 11203.
High Blood Press Cardiovasc Prev
June 2013
Department of Environmental and Occupational Health Sciences, State University of New York-Downstate School of Public Health, 450 Clarkson Ave., Box 43, Brooklyn, NY 11203, USA.
Introduction: Masked hypertension, i.e., normal clinic blood pressure but elevated blood pressure during normal daily activities as measured by ambulatory monitoring, is a common problem and a serious cardiovascular risk factor.
View Article and Find Full Text PDF